Neuro-autoimmune conditions and how to test for them.
Dr. Shimasaki is CEO of Moleculera Labs, the only lab in the world to test for autoimmune activity against neuronal targets in the brain that is used by clinics/practitioners across the world to identify encephalitic-type activity called “PANS/PANDAS” in children, and autoimmune encephalopathy in adults. It is characterised by many symptoms that are often considered psychiatric and not given any further biomedical exploration. He will explain the use of the Cunningham Panel, how to interpret the results, and its application in therapy. This will be the first of three webinars on this topic.
CPD is pending.